Clinical Research in Cardiology

, Volume 106, Issue 7, pp 525–532 | Cite as

Drop-out from cardiovascular magnetic resonance in a randomized controlled trial of ST-elevation myocardial infarction does not cause selection bias on endpoints

  • Peter Nørkjær Laursen
  • L. Holmvang
  • H. Kelbæk
  • N. Vejlstrup
  • T. Engstrøm
  • J. Lønborg
Original Paper
First Online:
Received:
Accepted:

Abstract

Background

The extent of selection bias due to drop-out in clinical trials of ST-elevation myocardial infarction (STEMI) using cardiovascular magnetic resonance (CMR) as surrogate endpoints is unknown. We sought to interrogate the characteristics and prognosis of patients who dropped out before acute CMR assessment compared to CMR-participants in a previously published double-blinded, placebo-controlled all-comer trial with CMR outcome as the primary endpoint.

Methods

Baseline characteristics and composite endpoint of all-cause mortality, heart failure and re-infarction after 30 days and 5 years of follow-up were assessed and compared between CMR-drop-outs and CMR-participants using the trial screening log and the Eastern Danish Heart Registry.

Results

The drop-out rate from acute CMR was 28% (n = 92). These patients had a significantly worse clinical risk profile upon admission as evaluated by the TIMI-risk score (3.7 (± 2.1) vs 4.0 (± 2.6), p = 0.043) and by left ventricular ejection fraction (43 (± 9) vs. 47 (± 10), p = 0.029). CMR drop-outs had a higher incidence of known hypertension (39% vs. 35%, p = 0.043), known diabetes (14% vs. 7%, p = 0.025), known cardiac disease (11% vs. 3%, p = 0.013) and known renal function disease (5% vs. 0%, p = 0.007). However, the 30-day and 5-years composite endpoint rate was not significantly higher among the CMR drop-out ((HR 1.43 (95%-CI 0.5; 3.97) (p = 0.5)) and (HR 1.31 (95%-CI 0.84; 2.05) (p = 0.24)).

Conclusion

CMR-drop-outs had a higher incidence of cardiovascular risk factors at baseline, a worse clinical risk profile upon admission. However, no significant difference was observed in the clinical endpoints between the groups.

Keywords

Leave Ventricular Ejection Fraction Cardiovascular Magnetic Resonance Charlson Comorbidity Index Exenatide Composite Endpoint 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Notes

Compliance with ethical standards

Funding

All expenses for this study were paid by The Heart Centre, Copenhagen University Hospital, Rigshospitalet.

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Eitel I, de WS, Wohrle J, Fuernau G, Lurz P, Pauschinger M et al (2014) Comprehensive prognosis assessment by CMR imaging after ST-segment elevation myocardial infarction. J Am Coll Cardiol 64(12): 1217–1226CrossRefPubMedGoogle Scholar
  2. 2.
    Lonborg J, Vejlstrup N, Kelbaek H, Holmvang L, Jorgensen E, Helqvist S et al (2013) Final infarct size measured by cardiovascular magnetic resonance in patients with ST elevation myocardial infarction predicts long-term clinical outcome: an observational study. Eur Heart J Cardiovasc Imaging 14(4):387–395CrossRefPubMedGoogle Scholar
  3. 3.
    Kelbaek H, Terkelsen CJ, Helqvist S, Lassen JF, Clemmensen P, Klovgaard L et al (2008) Randomized comparison of distal protection versus conventional treatment in primary percutaneous coronary intervention: the drug elution and distal protection in ST-elevation myocardial infarction (DEDICATION) trial. J Am Coll Cardiol 51(9):899–905CrossRefPubMedGoogle Scholar
  4. 4.
    Kelbaek H, Engstrom T, Ahtarovski KA, Lonborg J, Vejlstrup N, Pedersen F et al (2013) Deferred stent implantation in patients with ST-segment elevation myocardial infarction: a pilot study. EuroIntervention 8(10): 1126–1133CrossRefPubMedGoogle Scholar
  5. 5.
    Erlinge D, Gotberg M, Lang I, Holzer M, Noc M, Clemmensen P et al (2014) Rapid endovascular catheter core cooling combined with cold saline as an adjunct to percutaneous coronary intervention for the treatment of acute myocardial infarction. The CHILL-MI trial: a randomized controlled study of the use of central venous catheter core cooling combined with cold saline as an adjunct to percutaneous coronary intervention for the treatment of acute myocardial infarction. J Am Coll Cardiol 63(18): 1857–1865CrossRefPubMedGoogle Scholar
  6. 6.
    Heusch G (2013) Cardioprotection: chances and challenges of its translation to the clinic. Lancet 381(9861):166–175CrossRefPubMedGoogle Scholar
  7. 7.
    Kim HW, Farzaneh-Far A, Kim RJ (2009) Cardiovascular magnetic resonance in patients with myocardial infarction: current and emerging applications. J Am Coll Cardiol 55(1):1–16CrossRefPubMedGoogle Scholar
  8. 8.
    Perazzolo MM, Lima JA, Iliceto S (2011) MRI in acute myocardial infarction. Eur Heart J 32(3):284–293CrossRefGoogle Scholar
  9. 9.
    Desch S, Stiermaier T, de WS, Lurz P, Gutberlet M, Sandri M et al (2016) Thrombus aspiration in patients with st-segment elevation myocardial infarction presenting late after symptom onset. JACC Cardiovasc Interv 9(2): 113–122CrossRefPubMedGoogle Scholar
  10. 10.
    Ibanez B, Macaya C, Sanchez-Brunete V, Pizarro G, Fernandez-Friera L, Mateos A et al (2013) Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial. Circulation 128(14): 1495–1503CrossRefPubMedGoogle Scholar
  11. 11.
    McCann GP, Khan JN, Greenwood JP, Nazir S, Dalby M, Curzen N et al (2015) Complete versus lesion-only primary PCI: the randomized cardiovascular MR CvLPRIT substudy. J Am Coll Cardiol 66(24): 2713–2724CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Roolvink V, Ibanez B, Ottervanger JP, Pizarro G, van RN, Mateos A et al (2016) Early administration of intravenous Beta blockers in patients with ST-elevation myocardial infarction before primary PCI. J Am Coll CardiolGoogle Scholar
  13. 13.
    White SK, Frohlich GM, Sado DM, Maestrini V, Fontana M, Treibel TA et al (2015) Remote ischemic conditioning reduces myocardial infarct size and edema in patients with ST-segment elevation myocardial infarction. JACC Cardiovasc Interv 8 (1 Pt B):178–188CrossRefPubMedGoogle Scholar
  14. 14.
    Lonborg J, Vejlstrup N, Kelbaek H, Botker HE, Kim WY, Mathiasen AB et al (2012) Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction. Eur Heart J 33(12):1491–1499CrossRefPubMedGoogle Scholar
  15. 15.
    Hackel DB, Reimer KA, Ideker RE, Mikat EM, Hartwell TD, Parker CB et al (1984) Comparison of enzymatic and anatomic estimates of myocardial infarct size in man. Circulation 70(5):824–835CrossRefPubMedGoogle Scholar
  16. 16.
    Chia S, Senatore F, Raffel OC, Lee H, Wackers FJ, Jang IK (2008) Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. JACC Cardiovasc Interv 1(4):415–423CrossRefPubMedGoogle Scholar
  17. 17.
    Morrow DA, Antman EM, Charlesworth A, Cairns R, Murphy SA, de Lemos JA et al (2000) TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 102(17): 2031–2037CrossRefPubMedGoogle Scholar
  18. 18.
    Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383CrossRefPubMedGoogle Scholar
  19. 19.
    Von KM, Wagner EH, Saunders K (1992) A chronic disease score from automated pharmacy data. J Clin Epidemiol 45(2):197–203CrossRefGoogle Scholar
  20. 20.
    Svilaas T, Vlaar PJ, van der Horst IC, Diercks GF, de Smet BJ, van den Heuvel AF et al (2008) Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med 358(6): 557–567CrossRefPubMedGoogle Scholar
  21. 21.
    Frobert O, Lagerqvist B, Olivecrona GK, Omerovic E, Gudnason T, Maeng M et al (2013) Thrombus aspiration during ST-segment elevation myocardial infarction. N Engl J Med 369(17): 1587–1597CrossRefPubMedGoogle Scholar
  22. 22.
    Kelbaek H, Hofsten DE, Kober L, Helqvist S, Klovgaard L, Holmvang L et al (2016) Deferred versus conventional stent implantation in patients with ST-segment elevation myocardial infarction (DANAMI 3-DEFER): an open-label, randomised controlled trial. Lancet 387(10034): 2199–2206CrossRefPubMedGoogle Scholar
  23. 23.
    Frenkel WJ, Jongerius EJ, Mandjes-van Uitert MJ, van Munster BC, De Rooij SE (2014) Validation of the Charlson comorbidity index in acutely hospitalized elderly adults: a prospective cohort study. J Am Geriatr Soc 62(2):342–346CrossRefPubMedGoogle Scholar
  24. 24.
    Tu JV, Austin PC, Walld R, Roos L, Agras J, McDonald KM (2001) Development and validation of the Ontario acute myocardial infarction mortality prediction rules. J Am Coll Cardiol 37(4): 992–997CrossRefPubMedGoogle Scholar
  25. 25.
    Sterne JA, White IR, Carlin JB, Spratt M, Royston P, Kenward MG et al (2009) Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ 338:b2393CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Pedersen F, Butrymovich V, Kelbaek H, Wachtell K, Helqvist S, Kastrup J et al (2014) Short- and long-term cause of death in patients treated with primary PCI for STEMI. J Am Coll Cardiol 64(20): 2101–2108CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2017

Authors and Affiliations

  • Peter Nørkjær Laursen
    • 1
  • L. Holmvang
    • 1
  • H. Kelbæk
    • 2
  • N. Vejlstrup
    • 1
  • T. Engstrøm
    • 1
  • J. Lønborg
    • 1
  1. 1.Department of Cardiology, The Heart Centre, RigshospitaletCopenhagen University HospitalCopenhagenDenmark
  2. 2.Department of CardiologyRoskilde HospitalRoskildeDenmark

Personalised recommendations